Diabetes-related autoantibodies in children with acute lymphoblastic leukemia.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3322684)

Published in Diabetes Care on March 01, 2012

Authors

Carla Bizzarri, Rita M Pinto, Dario Pitocco, Elisa Astorri, Marco Cappa, Mohammed Hawa, Germana Giannone, Andrea Palermo, Ernesto Maddaloni, David R G Leslie, Paolo Pozzilli, IMDIAB Group

Articles by these authors

A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet (2004) 4.95

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes (2004) 4.44

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care (2008) 2.87

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet (2013) 2.45

Growth hormone treatment started in the first year of life in infants with chronic renal failure. Pediatr Nephrol (2009) 2.21

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med (2012) 2.01

The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med (2006) 1.77

Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med (2011) 1.69

Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene. J Clin Endocrinol Metab (2003) 1.67

Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J (2007) 1.59

Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox. Eur Heart J (2012) 1.54

Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome. Arthritis Rheumatol (2014) 1.53

Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women. Bone (2009) 1.50

Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care (2012) 1.49

Inverse correlation between serum free IGF-I and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes. Cytokine (2006) 1.44

The Charcot foot in diabetes. Diabetes Care (2011) 1.35

A novel insulin unit calculator for the management of type 1 diabetes. Diabetes Technol Ther (2011) 1.31

Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol (2007) 1.28

Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am J Hum Genet (2003) 1.27

Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care (2008) 1.27

Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab (2006) 1.26

Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur Heart J (2011) 1.17

Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care (2002) 1.17

Autoimmune thyroid diseases in children. J Thyroid Res (2010) 1.14

The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto's thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up. Clin Endocrinol (Oxf) (2012) 1.11

Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol (2003) 1.09

Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care (2007) 1.07

Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency. J Pediatr (2002) 1.07

The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care (2007) 1.07

The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control. Diabetes Care (2008) 1.05

Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus. Diabetes Technol Ther (2013) 1.05

No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care (2010) 1.03

Glycemic risk factors of diabetic vascular complications: the role of glycemic variability. Diabetes Metab Res Rev (2009) 1.01

Is glucose control important for prevention of cardiovascular disease in diabetes? Diabetes Care (2013) 1.01

Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr (2014) 0.99

Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome. Diabetes Care (2012) 0.99

Sexual dimorphism of body composition and insulin sensitivity across pubertal development in obese Caucasian subjects. Eur J Endocrinol (2009) 0.98

Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism. Pediatr Res (2003) 0.98

Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy. Diabetes Metab Res Rev (2012) 0.97

COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. Eur Heart J (2009) 0.97

Maternal age at birth and childhood type 1 diabetes: a pooled analysis of 30 observational studies. Diabetes (2009) 0.97

Thyroid morphology and subclinical hypothyroidism in children and adolescents with Williams syndrome. J Pediatr (2007) 0.97

Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children. Eur J Endocrinol (2009) 0.97

Obese children with low birth weight demonstrate impaired beta-cell function during oral glucose tolerance test. J Clin Endocrinol Metab (2009) 0.96

Adiponectin and bone mass density: The InCHIANTI study. Bone (2010) 0.96

Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies. Diabetes Care (2012) 0.96

Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study. Diabetes (2010) 0.96

Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study. Diabetes Care (2004) 0.96

Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain. Diabetes Metab Res Rev (2013) 0.95

C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study. Diabetes (2011) 0.95

Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin. Diabetes Metab Res Rev (2013) 0.95

Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. Hum Immunol (2008) 0.94

Glucose control in diabetes. Diabetes Metab Res Rev (2004) 0.94

Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Cell Transplant (2006) 0.92

Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients. Heart (2012) 0.92

Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus. J Diabetes Res (2013) 0.92

Epigenetics in autoimmune diseases with focus on type 1 diabetes. Diabetes Metab Res Rev (2013) 0.92

Effect of ghrelin on bone mass density: the InChianti study. Bone (2011) 0.92

Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability. Stroke (2011) 0.91

Endothelial progenitor cells and their potential therapeutic applications. Regen Med (2008) 0.91

Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors. J Clin Endocrinol Metab (2004) 0.91

Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity. Clin Endocrinol (Oxf) (2015) 0.91

Effect of α-lipoic acid on platelet reactivity in type 1 diabetic patients. Diabetes Care (2012) 0.89

Association of serum interleukin-8 levels with the degree of fibrosis in infants with chronic liver disease. J Pediatr Gastroenterol Nutr (2004) 0.89

A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus. J Pediatr Endocrinol Metab (2005) 0.89

Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. J Immunol (2010) 0.89

Beta-cell protection and therapy for latent autoimmune diabetes in adults. Diabetes Care (2009) 0.89

Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress. Free Radic Biol Med (2009) 0.89

The Italian National Survey for Prader-Willi syndrome: an epidemiologic study. Am J Med Genet A (2008) 0.88

Benefits of caloric restriction for cardiometabolic health, including type 2 diabetes mellitus risk. Diabetes Metab Res Rev (2014) 0.88

Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche. Eur J Endocrinol (2011) 0.88

Environmental risk factors for type 1 diabetes in Rome and province. Arch Dis Child (2003) 0.87

Recombinant human GH replacement therapy in children with pseudohypoparathyroidism type Ia: first study on the effect on growth. J Clin Endocrinol Metab (2010) 0.87

Endocrine autoimmunity in Turner syndrome. Ital J Pediatr (2013) 0.87

Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study). Pediatr Diabetes (2006) 0.87

Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy. Pediatr Diabetes (2009) 0.87

Use of metformin in pediatric age. Pediatr Diabetes (2011) 0.86

Thyroid function tests in obese prepubertal children: correlations with insulin sensitivity and body fat distribution. Horm Res Paediatr (2012) 0.86

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: report of seven additional sicilian patients and overview of the overall series from sicily. Horm Res Paediatr (2014) 0.86

Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes. J Autoimmun (2006) 0.86

Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev (2002) 0.86

Adrenoleukodystrophy. Endocr Dev (2010) 0.86

Group of signs: a new method to evaluate glycemic variability. J Diabetes Sci Technol (2008) 0.86

Inflammation-related effects of adjuvant influenza A vaccination on platelet activation and cardiac autonomic function. J Intern Med (2010) 0.86

Routine screening by brain magnetic resonance imaging is not indicated in every girl with onset of puberty between the ages of 6 and 8 years. J Clin Endocrinol Metab (2014) 0.86

Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit. Diabetes Technol Ther (2011) 0.86

The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life. J Clin Endocrinol Metab (2013) 0.85

Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: action LADA 6. Cytokine (2012) 0.85

A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8). Diabetes Technol Ther (2003) 0.85

Retracted Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial. Diabetes Care (2014) 0.85